Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Elgemtumab
Trade Name
Synonyms LJM716|LJM-716
Drug Descriptions

Elgemtumab (LJM716) is a monoclonal antibody that targets ErbB3 (Her3) and prevents its transition into an active conformation, resulting in inhibition of ligand-dependent and ligand-independent downstream signaling and decreased tumor cell proliferation (PMID: 23928993, PMID: 27942917).

DrugClasses HER3 (ERBB3) Antibody 18
CAS Registry Number 1512559-37-3
NCIT ID C101895


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Alpelisib + Elgemtumab Alpelisib Elgemtumab 0 1
Alpelisib + Elgemtumab + Trastuzumab Alpelisib Elgemtumab Trastuzumab 0 1
Buparlisib + Elgemtumab Buparlisib Elgemtumab 0 0
Elgemtumab Elgemtumab 0 0
Elgemtumab + Neratinib Elgemtumab Neratinib 0 0
Elgemtumab + Trastuzumab Elgemtumab Trastuzumab 0 1

Additional content available in CKB BOOST